Adicet Bio, Inc.
ACET· Nasdaq
Released Mar 11, 2021, after the close
10-K filed Mar 12, 2021, 71 days after period end · 0001564590-21-012664
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019 | Q4 2018 | Q4 2017 |
|---|---|---|---|---|
| Net Income | -$8.96M | -$28.89M | -$5.76M | -$23.05M |
| EPS Diluted | — | -$0.79 | -$0.21 | -$5.11 |
Adicet Bio, Inc. · CIK 1720580 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.